Ask to take part

Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.

Contact Information:

Study Location:

Skip to Main Content
English | Cymraeg
Be Part of Research - Trial Details - Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer

Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer

Medical Conditions

Prostatic Neoplasms


This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.


RATIONALE: Giving dexamethasone together with aspirin and diethylstilbestrol may be effective in lowering prostate-specific antigen levels and may slow or stop the growth of prostate cancer. It is not yet known which schedule of dexamethasone, aspirin, and diethylstilbestrol is more effective in treating prostate cancer.

PURPOSE: This randomized phase III trial is studying dexamethasone and aspirin when given together with two different schedules of diethylstilbestrol to compare how well they work in treating patients with locally advanced or metastatic prostate cancer.

Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.  

The recruitment start and end dates are as follows:

Dec 2002 Dec 2002

Publications

"Shamash J, Powles T, Sarker SJ, Protheroe A, Mithal N, Mills R, Beard R, Wilson P, Tranter N, O'Brien N, McFaul S, Oliver T. A multi-centre randomised phase III trial of Dexamethasone vs Dexamethasone and diethylstilbestrol in castration-resistant prostate cancer: immediate vs deferred Diethylstilbestrol. Br J Cancer. 2011 Feb 15;104(4):620-8. doi: 10.1038/bjc.2011.7. Epub 2011 Feb 1."; "21285990"

INTERVENTIONAL

Intervention Type : DRUG

Intervention Type : DRUG

Intervention Type : DRUG



You can take part if:



You may not be able to take part if:


This is in the inclusion criteria above


Below are the locations for where you can take part in the trial. Please note that not all sites may be open.

  • Bristol Haematology and Oncology Centre
    Bristol
    England
    BS2 8ED
  • Saint Bartholomew's Hospital
    London
    England
    EC1A 7BE
  • Maidstone Hospital
    Maidstone
    England
    ME16 9QQ
  • Churchill Hospital
    Oxford
    England
    OX3 7LJ
  • Weston General Hospital
    Weston-super-Mare
    England
    BS23 4TQ
  • Cancer Care Centre at York Hospital
    York
    England
    Y031 8HE
  • Oldchurch Hospital
    Romford
    England
    RM7 OBE
  • Torbay Hospital
    Torquay Devon
    England
    TQ2 7AA
  • Kent and Canterbury Hospital
    Canterbury
    England
    CT2 3NG
  • Eastbourne District General Hospital
    Eastbourne
    England
    BN21 2UD
  • Worthing Hospital
    Worthing
    England
    BN11 2DH
  • Whipps Cross Hospital
    London
    England
    E11 1NR
  • Milton Keynes General Hospital
    Milton Keynes
    England
    MK6 5LD
  • Burnley General Hospital
    Burnley
    England
    BB10 2PQ
  • Chelsea Westminster Hospital
    London
    England
    SW10 9NH


The study is sponsored by St. Bartholomew's Hospital





We'd like your feedback

Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.


Is this study information helpful?

What will you do next?

Read full details for Trial ID: NCT00316927
Last updated 25 June 2013

This page is to help you find out about a research study and if you may be able to take part

You can print or share the study information with your GP/healthcare provider or contact the research team directly.